The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 2, 2007, Pages e1-

  Ihde, Stefan K A ^a   Konstantinovic, Vitomir S ^b  

^a Gommiswald Dental Clinic   (Switzerland)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34447302328     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.02.004     Document Type: Article

References (23)

1. Blitzer A., and Sulica L. Botulinum toxin: basic science and clinical uses in otolaryngology. Laryngoscope 111 2 (2001) 218-226
2. Ihde S. Utilisation of prophylactique de la toxine botulique en implantologie dentaire. Implantodontie 14 (2005) 51-55 [French].
3. Ihde S. Utilisation therapeutique de la toxine botulique dans le traitment d'entretien en implantologie dentaire. Implantodontie 14 (2005) 56-61 [French]
4. Yin S., Stucker F.J., and Nathan C.A. Clinical application of botulinum toxin in otolaryngology, head and neck practice. [brief review]. J La State Med Soc 153 2 (2001) 92-97
5. Brin M.F., Lew M.F., Adler C.H., Comella C.L., Factor S.A., Jankovic J., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia. Neurology 53 7 (1999) 1431-1438
6. Brashear A., Lew M.F., Dykstra D.D., Comella C.L., Factor S.A., Rodnitzky R.L., et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 53 7 (1999) 1439-1446
7. Lew M.F., Adornato B.T., Duane D.D., Dykstra D.D., Factor S.A., Massey J.M., et al. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia. Neurology 49 3 (1997) 701-707
8. Caird D. Dysport in aesthetic medicine safety report: the upper face, forehead, glabella and lateral canthus (crow's feet) (2005), Ipsen Pharma, Ettlingen, Germany
9. Myobloc [product information] (2005), Solstice Neurosciences, Malvern, PA
10. NeuroBloc [product overview] (2005), European Medicines Agency, San Francisco, CA
11. Ihde S. Prophylactic use of botulinum toxin in dental implantology. CMF Impl Dir 1 (2007) 29-34
12. von Lindern J.J., Niederhagen B., Berge S., and Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 61 7 (2003) 774-778
13. Umstadt H.E. Behandlung hyperaktiver Kaumuskulatur mit Botulinum toxin A. Zahnheilkunde 20 (2004) 475-484 [German].
14. Freund B., Schwartz M., and Symington J.M. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 38 5 (2000) 466-471
15. von Lindern J.J. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction. Acta Neurol Belg 101 1 (2001) 39-41
16. Freund B.J., and Schwartz M. Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A. Headache 42 10 (2002) 1033-1037
17. Borodic G.E., and Acquadro M.A. The use of botulinum toxin for the treatment of chronic facial pain. J Pain 3 1 (2002) 21-27
18. Zieglar C.M., Haag C., and Mühling J. Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Invest 7 (2003) 52-55
19. Karacalar A., Yilmaz N., Bilgici A., Bas B., and Akan H. Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience. J Craniofac Surg 16 3 (2005) 476-481
20. Cote T.R., Mohan A.K., Polder J.A., Walton M.K., and Braun M.M. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 53 3 (2005) 407-415
21. Sankhla C., Lai E.C., and Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry 65 (1998) 722-728
22. Tan E.K., and Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131 (2000) 211-216
23. Kim H.J., Yum K.W., Lee S.S., and Heo S.S. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Dermatol Surg 29 (2003) 484-489